Published articles

Search collections:

Sort by:	Display results:	Output format:

Published articles	1 records found	Search took 0.01 seconds.

8 p, 257.6 KB

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen / Prat, A. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Parker, J. S. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Fan, C. (LUniversity of North Carolina. Lineberger Comprehensive Cancer Center) ; Cheang, M. C. U. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Miller, L. D. (Wake Forest School of Medicine. Department of Cancer Biology) ; Bergh, Jonas (Manchester University. Department of Medical Oncology) ; Chia, S. K. L. (British Columbia Cancer Agency) ; Bernard, P. S. (University of Utah Health Sciences Center. Department of Pathology) ; Nielsen, T. O. (University of British Columbia. Department of Pathology) ; Ellis, M. J. (Siteman Cancer Center at Washington University. Department of Medicine) ; Carey, L. A. (University of North Carolina. Deparment of Medicine) ; Perou, Charles M. (University of North Carolina. Pathology & Laboratory Medicine)
ER-positive (ER+) breast cancer includes all of the intrinsic molecular subtypes, although the luminal A and B subtypes predominate. In this study, we evaluated the ability of six clinically relevant genomic signatures to predict relapse in patients with ER+ tumors treated with adjuvant tamoxifen only. [...]
2012 - DOI (Digital Object Identifier)

10.1093/annonc/mds080
Annals of oncology, Vol. 23 Núm. 11 (november 2012) , p. 2866-2873

Detailed record -

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.